NASDAQ:VKTX

Viking Therapeutics Stock Draws Wall Street Attention with Obesity Pill Competition Growing
····

Viking Therapeutics Stock Draws Wall Street Attention with Obesity Pill Competition Growing

Viking Therapeutics shares rose 1.7% to $32.19 after Lake Street initiated coverage with a Buy rating and an $89 price target, citing potential for its obesity drug VK2735. Phase 2 trial data showed up to 12.2% mean weight loss in 13 weeks. The company’s market cap stood at $3.72 billion. Board elections and auditor approval were disclosed in a May 26 SEC filing.
May 28, 2026

Stock Market Today

  • XRO and WTC Shares: Key ASX Stock Insights and Performance Analysis
    May 28, 2026, 4:40 PM EDT. Xero Ltd (ASX:XRO) and WiseTech Global Ltd (ASX:WTC) are notable Australian Securities Exchange stocks to watch. Since 2025, XRO shares have fallen 33.6%, while WTC shares are 70% below their 52-week high. Xero, a cloud-based accounting software leader, grew revenues by 26.4% annually to $1.7 billion in FY24 with a net profit rise from -$9 million to $175 million and a 14.3% return on equity (ROE). WiseTech, specializing in logistics software, reported revenue growth of 27.1% yearly to $1.04 billion with net profit up from $108 million to $263 million and a 12.8% ROE. These fundamentals reflect significant growth but require further valuation context for investing decisions.